























Number of US valley fever cases, 1995-2011 
An estimated 150,000 more cases go undiagnosed every year. More than 
70% of cases occur in Arizona and 25% occur in California.1
   
Coccidioidomycosis, a fungal disease called “cocci” or “valley fever,”  is a major 
cause of community-acquired pneumonia in the southwestern US. 
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• In 2011, more than 20,000 
   cases were reported in the
   US, twice as many cases as
   tuberculosis. 
• Nearly 75% of valley fever 
   victims miss work or school 
   for about two weeks.2 
• More than 40% of valley 
   fever victims are hospitalized. 
The average cost of a hospital 
   stay for valley fever is almost 
$50,000.2 
A costly problem 
Challenges arise in unpredictable ways 
• More people exposed to Coccidioides due to increased travel and  
    relocation to endemic areas 
•  Changes in temperature and rainfall can affect the growth and 
    distribution of the fungus 
•  Changes in how cases are being detected 
    and reported 
i
From soil to lungs 
Valley fever occurs in people 
who live in or have traveled to 
areas where Coccidioides is 
endemic, or native and common 
n the environment. It is found 
most often in the southwestern 
United  States (especially Arizona 
and California) and parts of




Valley fever is an illness caused by the fungus Coccidioides, which lives in 
soil. People can become infected by inhaling fungal spores. This can cause 
flu-like symptoms that may last from weeks to months. 
Common symptoms.  Unusual cause. 
Because the symptoms (fever, cough, headache, rash, muscle aches, or joint pain) are similar to other common 
illnesses, diagnosis and treatment are often delayed. In a very small proportion of people, the infection can cause 
chronic pneumonia, spread from the lungs to the rest of the body and cause meningitis (brain or spine infection), 
or even death. 
People at risk 
Anyone can get valley fever by inhaling airborne spores in 
endemic areas.  It is most common among older adults, 
particularly those ages 60 and older, but more young people 
are getting the disease. Valley fever cannot spread from 
person to person. 
Some groups of people, including military personnel, 
US-Mexico border patrol agents, prison inmates, archaeolo­
gists, or construction workers have high levels of exposure to 
dusty environments where Coccidioides is common. Some 
groups of people are at increased risk for developing more 
severe forms of valley fever, including African Americans, 
Asians, women in their third trimester of pregnancy, and 
people with weak immune systems. 
What is CDC doing ?	 What else can be done? 
• 	 Supporting states in endemic areas to 
    track and better understand the impact 
    of valley fever on local communities	 
• 	 Monitoring the epidemiology of valley 
    fever to understand national trends in 
disease 
• 	 Serving as a reference laboratory and 
    providing training in laboratory diagnosis 	
• Increase capability to track illnesses throughout the US 
    and throughout the western hemisphere in areas where 
    valley fever is endemic 
• Further research into ways to reduce the severity or 
    duration of illness, including early diagnosis and 

    antifungal treatment
 
• Expand awareness of valley fever among healthcare 
    providers and the general public in order to minimize 

    delays in diagnosis and treatment
 
• 	 Support ongoing research into vaccine development 
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